Skip to main content

MERGERS: AMO SR initiated an administrative proceedings in the matter of a merger of the undertakings Pro Diagnostic Group, a.s., Ribera Salud, S.A., Pro Partners Holding, a.s., and MUDr. Ježík

Updated on:
On 22 December 2020 the Antimonopoly Office of the Slovak Republic, the Division of Concentrations, (hereafter “the Office“) initiated an administrative proceedings in the matter of a merger, which according to the merger notification is grounded in the change of control over a joint venture (the company Pro Diagnostic Group, a.s., Bratislava, hereafter “PDG“) grounded in the accession of another controlling shareholder. Thus, after the merger, PDG will be jointly controlled by the undertakings Ribera Salud, S.A., the Kingdom of Spain, Pro Partners Holding, a.s., Bratislava and MUDr. Ježík (as a new entering shareholder).

Q 86.9 Other human health activities

Third parties, namely natural and legal persons may submit their comments, objections and information on notified mergers to the Office. We request the third parties to submit their comments to the Office as soon as possible following the publishing of notification what may allow the Office to deal with these comments in the first phase of assessment of notified merger with respecting the legal periods.